PTC (NASDAQ: PTC) today reported financial results for its fourth fiscal quarter and full fiscal year ended September 30, ...

or 20.61% annualized — at Stock Options Channel we call this the YieldBoost. Below is a chart showing the trailing twelve month trading history for PTC Inc, and highlighting in green where the $ ...

PTC Inc. ( (PTC) ) has released its Q4 earnings. Here is a breakdown of the information PTC Inc. presented to its investors. PTC Inc. is a ...

In a Q&A session Monday afternoon, Heppelmann revealed that PTC's AR business represents about $20 million in revenue with a 100 percent growth rate. He said Vuforia Engine, the core technology ...

Analyst Joseph Thome of TD Cowen maintained a Hold rating on PTC Therapeutics (PTCT – Research Report), boosting the price target to $38.00. Joseph Thome’s rating is based on PTC Therapeutics’ strong ...

While numerous in vitro and animal studies suggest a possible role for sex steroids in thyroid cancer tumorigenesis and progression, in particular with respect to PTC, clinical studies have been ...

Flip through the slideshow below for 20 excellent songs written about cities, from Prince's impactful "Baltimore" to George Strait's iconic "Amarillo By Morning." ...

The Dividend History page provides a single page to review all of the aggregated Dividend payment information. Visit our Dividend Calendar: Our partner, Quotemedia, provides the upcoming ex ...

Analysts expect PTC Therapeutics to report an earnings per share (EPS) of $-1.44. PTC Therapeutics bulls will hope to hear the company announce they've not only beaten that estimate, but also to ...

Several hypotheses have been proposed to explain the disparities observed between men and women with respect to the incidence of thyroid cancer, including differential screening, gender-specific ...